Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Objective: Treating sarcopenia remains a challenge, and nutritional interventions present promising approaches. We summarize the effects of leucine supplementation in treating older individuals with sarcopenia associated with aging or to specific disorders, and we focus on the effect of leucine supplementation on various sarcopenia criteria, e.g., muscular strength, lean mass, and physical performance. Methods: A literature search for articles related to this topic was performed on the relevant databases, e.g., the PubMed/Medline, Embase, EBSCO, Cochrane, Lilacs, and Dialnet. The identified articles were reviewed according to Preferred Reporting Items for Systematic reviews and meta-analyses (PRISMA) guidelines. Results: Of the 163 articles we consulted, 23 met our inclusion criteria, analysing the effect of leucine or leucine-enriched protein in the treatment of sarcopenia, and 13 of these studies were based on randomized and placebo-controlled trials (RCTs). In overall terms, the published results show that administration of leucine or leucine-enriched proteins (range 1.2–6 g leucine/day) is well-tolerated and significantly improves sarcopenia in elderly individuals, mainly by improving lean muscle-mass content and in this case most protocols also include vitamin D co-administration. The effect of muscular strength showed mix results, and the effect on physical performance has seldom been studied. For sarcopenia-associated with specific disorders, the most promising effects of leucine supplementation are reported for the rehabilitation of post-stroke patients and in those with liver cirrhosis. Further placebo-controlled trials will be necessary to determine the effects of leucine and to evaluate sarcopenia with the criteria recommended by official Working Groups, thereby limiting the variability of methodological issues for sarcopenia measurement across studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 4×
“Regarding methodological issues, our analysis highlighted that different sarcopenia evaluation methods have often failed to adequately meet the criteria proposed by the international guidelines [1,72,73].”
BackgroundInfluentialSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“The loss of muscle mass and strength (sarcopenia) and its functional consequences such as reduced walking speed can occur to a varying degree both as a part of physiological changes during aging [55] or in some pathological conditions increasing the amount of time in bed which in itself can result in catabolism and a…”
BackgroundBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 1×
“Regarding methodological issues, our analysis highlighted that different sarcopenia evaluation methods have often failed to adequately meet the criteria proposed by the international guidelines [1,72,73].”
Tang, J. E., Moore, D. R., Kujbida, G. W., Tarnopolsky, M. A., & Phillips, S. M. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00076.2009 · Cited by 998
Skeletal muscle performance and ageing
Tieland, M., Trouwborst, I., & Clark, B. C. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12238 · Cited by 904 · cited 2×
“In contrast, the sarcopenia criteria related to muscle strength and physical performance are not only mediated by an efficient and proper lean mass, but also by a central nervous system component which forms a neuro-muscular (motor) unit [3,70].”
BackgroundAn overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888 · cited 1×
“In fact, the decrease in skeletal muscle strength induced by sarcopenia, known as dynapenia, is even more precipitous, occurring at an annual rate of ∼ 2–3% [2,3] and it is estimated that more than 20% of adults aged over 65 years, and over 50% of those aged at least 80 years are sarcopenic [4].”
BackgroundBauer, J. M., Verlaan, S., Bautmans, I., Brandt, K., Donini, L. M., Maggio, M., McMurdo, M. E. T., Mets, T., Seal, C., Wijers, S. L., et al. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.05.021 · Cited by 670 · cited 3×
“Bauer 2015 [38] 6 Whey protein (40 g), carbohydrates (18 g), fat (6 g), vit-D (1600 IU) and mixture of vitamins, minerals and fibers Isocaloric product without protein content 13 weeks Not altered Improved Not altered”
BackgroundSrikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010805 · Cited by 600 · cited 1×
“disability [12], and type-II diabetes [13,14], which all have a negative impact on their quality of life and premature mortality.”
BackgroundBreen, L., & Phillips, S. M. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-68 · Cited by 576 · cited 1×
“Moreover, older adults exhibit a decreased anabolic response to protein feeding [17,18], which is a mechanism underpinning the loss of muscle mass in sarcopenic individuals.”
BackgroundKim, H. K., Suzuki, T., Saito, K., Yoshida, H., Kobayashi, H., Kato, H., & Katayama, M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03776.x · Cited by 551
McGregor, R. A., Cameron-Smith, D., & Poppitt, S. D. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-9 · Cited by 532 · cited 1×
“is increasingly recognised as playing an important role in normal muscle function, and low vitamin D status is associated with an increased risk of falls and proximal weakness [68] and these effects are more prominent in male individuals [69].”
BackgroundRondanelli, M., Klersy, C., Terracol, G., Talluri, J., Maugeri, R., Guido, D., Faliva, M. A., Solerte, B. S., Fioravanti, M., Lukaski, H., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.113357 · Cited by 412 · cited 5×
“The supplementation’s protocols tested in the studies were generally well tolerated, and none of the adverse events resulted in discontinuation of product consumption or study participation [32,33,37,40,47,48].”
BackgroundMethodInfluentialRieu, I., Balage, M., Sornet, C., Giraudet, C., Pujos, E., Grizard, J., Mosoni, L., & Dardevet, D. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.110742 · Cited by 410
Muscle Mass Index As a Predictor of Longevity in Older Adults
Srikanthan, P., & Karlamangla, A. S. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.02.007 · Cited by 382 · cited 2×
“disability [12], and type-II diabetes [13,14], which all have a negative impact on their quality of life and premature mortality.”
BackgroundMethodSarcopenia and sarcopenic obesity
Choi, K. M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.193 · Cited by 344
Verreijen, A. M., Verlaan, S., Engberink, M. F., Swinkels, S., de Vogel-van den Bosch, J., & Weijs, P. J. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.090290 · Cited by 237
Nutritional strategies to attenuate muscle disuse atrophy
Wall, B. T., & van Loon, L. J. (2013) · Nutrition Reviews · doi:10.1111/nure.12019 · Cited by 228
Bukhari, S. S. I., Phillips, B. E., Wilkinson, D. J., Limb, M. C., Rankin, D., Mitchell, W. K., Kobayashi, H., Greenhaff, P. L., Smith, K., & Atherton, P. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00481.2014 · Cited by 162 · cited 3×
“, 2015 [35] 66 ± 25 16 100% United Kingdom Non-specified residence YES(EWGSOP) Appendicular muscle mass and skeletal muscle mass index by DXA (Janssen criteria) Not determined Not determined”
BackgroundMethodResultKomar, B., Schwingshackl, L., & Hoffmann, G. (2015) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0559-4 · Cited by 161
Devries, M. C., McGlory, C., Bolster, D. R., Kamil, A., Rahn, M., Harkness, L., Baker, S. K., & Phillips, S. M. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx028 · Cited by 112 · cited 1×
“However, several studies were performed only in men [32–34,40,42,46,51] or in women [35,36,44].”
ResultDynapenic obesity and the risk of incident Type 2 diabetes: the english longitudinal study of ageing
Cuthbertson, D. J., Bell, J. A., Ng, S. Y., Kemp, G. J., Kivimaki, M., & Hamer, M. (2016) · Diabetic Medicine · doi:10.1111/dme.12991 · Cited by 86 · cited 1×
“disability [12], and type-II diabetes [13,14], which all have a negative impact on their quality of life and premature mortality.”
BackgroundKirk, B., Mooney, K., Amirabdollahian, F., & Khaiyat, O. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00445 · Cited by 72
Poggiogalle, E., Migliaccio, S., Lenzi, A., & Donini, L. M. (2014) · Endocrine · doi:10.1007/s12020-014-0315-x · Cited by 67
Holwerda, A. M., Paulussen, K. J. M., Overkamp, M., Goessens, J. P. B., Kramer, I.-F., Wodzig, W. K. W. H., Verdijk, L. B., de Groot, L. C. P. G. M., & van Loon, L. J. C. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2019 · Cited by 36 · cited 3×
“Holwerda 2019 [42] 2,8 (Group 1) Group 1: Whey protein (20,7 g, with 2.”
BackgroundInfluential
Cited by
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
Izzo, A., Massimino, E., Riccardi, G., & Della Pepa, G. (2021) · Nutrients · doi:10.3390/nu13010183 · Cited by 418
Cereda, E., Pisati, R., Rondanelli, M., & Caccialanza, R. (2022) · Nutrients · doi:10.3390/nu14071524 · Cited by 139
Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial
Martínez-Arnau, F. M., Fonfría-Vivas, R., Buigues, C., Castillo, Y., Molina, P., Hoogland, A. J., van Doesburg, F., Pruimboom, L., Fernández-Garrido, J., & Cauli, O. (2020) · Nutrients · doi:10.3390/nu12040932 · Cited by 120
Self-citationDevries, M. C., McGlory, C., Bolster, D. R., Kamil, A., Rahn, M., Harkness, L., Baker, S. K., & Phillips, S. M. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx028 · Cited by 112
Whaikid, P., & Piaseu, N. (2024) · Epidemiology and Health · doi:10.4178/epih.e2024030 · Cited by 52
Metadata
- Authors
- Martínez-Arnau, F. M., Fonfría-Vivas, R., & Cauli, O.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-10-17
- Volume
- 11
- Issue
- 10
- Pages
- 2504
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2980794190
- Cited by
- 129
- References
- 27
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.